
ATHE P/E Ratio
P/E Ratio as of Jun 13, 2025: -2.79
Average-2.80
Median-2.85
Minimum-3.07
Maximum-2.40
-2.79
Past Month-0.19 (7.31%)
The P/E ratio for ATHE is -2.79 as of Jun 13, 2025. This represents a increase of 76.58% compared to its 12-month average P/E ratio of -1.58. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Alterity Therapeutics Ltd - ADR P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Alterity Therapeutics Ltd - ADR’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Alterity Therapeutics Ltd - ADR to industry peers.
Alterity Therapeutics Ltd - ADR P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Alterity Therapeutics Ltd - ADR’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Alterity Therapeutics Ltd - ADR to industry peers.
ATHE P/E Ratio Insights
See Alterity Therapeutics Ltd - ADR’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ATHE
Order type
Buy in
Order amount
Est. shares
0 shares
ATHE P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $4.5994 | -2.91 |
May 1, 2025 | $3.45 | -2.19 |
Apr 1, 2025 | $3.18 | -2.02 |
Mar 3, 2025 | $3.64 | -2.31 |
Feb 3, 2025 | $4.99 | -2.42 |
Jan 2, 2025 | $3.73 | -1.81 |
ATHE End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -2.79 | +73.29% |
2024 | -1.61 | +49.07% |
2023 | -1.08 | -28.00% |
2022 | -1.50 | -43.61% |
2021 | -2.66 | +21.46% |
2020 | -2.19 | — |
FAQs About Alterity Therapeutics Ltd - ADR (ATHE) P/E ratio
The latest P/E ratio of ATHE is -2.79, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Alterity Therapeutics Ltd - ADR’s last 12-month average P/E ratio is -1.58, compared to its current P/E ratio of -2.79. This reflects a increase of 76.58%.
Alterity Therapeutics Ltd - ADR’s current P/E ratio of -2.79 is higher than its last 12-month average P/E of -1.58. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Alterity Therapeutics Ltd - ADR’s average P/E ratio over the last 3 years is -1.46. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Alterity Therapeutics Ltd - ADR’s average P/E ratio over the last 5 years is -2.02. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.